Skip to content

Rachel E. Fargason

3 papers in the library · 29 citations · publishing 2023-2025

Papers

Sort Most recent Most cited

Dextromethorphan in Cough Syrup: The Poor Man's Psychosis.

Psychopharmacology Bulletin August 12, 2025 Bridgette Martinak, Ramy A Bolis, J. Black et al.

Dextromethorphan (3-methoxy-N-methylmorphinan), also known as "DXM" and "the poor man's PCP," is a synthetically produced drug that is available in more than 140 over-the-counter cough and cold preparations. Dextromethorphan (DXM) has overtaken codeine as the most widely used cough suppressant due to its availability, efficacy, and safety profile at directed doses. However, DXM is subject to...

Manic episode following psilocybin use in a man with bipolar II disorder: a case report

Frontiers in Psychiatry September 22, 2023 Haniya J Halim, Bradley G. Burk, Rachel E. Fargason et al. 13 citations

There has been an increase in research on the topic of psychedelic substances and their effects as treatment options in neuropsychiatric conditions. Psilocybin is a psychedelic drug that has recently garnered increased interest as an effective treatment modality for treatment-resistant depression, depression associated with terminal conditions, certain substance use disorders, and...

Delta-8-THC association with psychosis: A case report with literature review

Frontiers in Psychiatry February 20, 2023 Chelsea R. Miller, Bradley G. Burk, Rachel E. Fargason et al. 16 citations

Background Cannabis (Δ 9 -THC) is the most commonly consumed illicit drug. The Agricultural Improvement Act of 2018 removed hemp, a strain of Cannabis sativa , as a controlled substance. This law allowed the plant to be processed into its components, which contain <0.3% Δ 9 -THC. As a result, delta-8-tetrahydrocannabinol (Δ 8 -THC), a federally unregulated substance, grew in popularity in 2020....